Get Started

AVIR

NASD Atea Pharmaceuticals, Inc.
Oct 23, 2026 · 5:15 AM ET EOD Market Closed

$4.05 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.05, $0.12 below the day’s high of $4.17

YTD change
+13.45%
vs 20-day SMA
-17.43%
vs 200-day SMA
-17.45%

Price ranges

Previous day
$4.02 $4.17
open $4.08 close $4.05
-$0.03 (-0.74%)
Today
$4.02 $4.17
$4.05
Past week
$4.05 $4.81
from $4.63 now $4.05
-$0.58 (-12.53%)
Past month
$4.05 $5.31
from $5.28 now $4.05
-$1.23 (-23.30%)
This year
$3.29 $6.45
from $3.57 now $4.05
+$0.48 (+13.45%)

Price & Performance

-1.47 (-26.63%) / 6M

$3.91$4.60$5.28$5.97Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 95.7% away from all-time highs of $94.17
  • AVIR is up 13% since the beginning of the year
  • AVIR is up 23% over the past 12 months
  • AVIR is down 23% over the past 1 month
  • 11% of all AVIR investors are betting against AVIR

AVIR reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +27.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.41
Earnings momentum +18.8% Quarterly EPS growth
Quarterly change +18.8%

Valuation

P/E ratio N/A
Enterprise value $107.6M
Beta -0.30

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$219.5M
Debt$424.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $324.8M

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.28 +2.04%
MRNA Moderna, Inc. $202.63 -17.57%
RVMD Revolution Medicines, Inc. $187.69 -3.39%
ROIV Roivant Sciences Ltd. $37.45 +1.77%
BNTX BioNTech SE Sponsored ADR $89.67 -1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.